EULAR Rheumatology Open
Publisher: Elsevier · ISSN 3050-7081 · 79 articles
- Parent-child (dis)agreement in patient-reported outcomes in juvenile idiopathic arthritis: the role of child depression and caregiver burden
- ‘Let’s work alongside it’: healthcare professionals’ perspectives of generative AI in supporting care at home in paediatric rheumatology
- The EULAR points to consider regarding the development of criteria for the assessment of the disease activity in adult-onset Still’s disease
- The proportion of tuberculosis disease among adult patients receiving biologic agents at a tertiary centre in Kenya
- Hallmarks of aging in systemic sclerosis: implications for pathogenesis, multimorbidity, and therapeutic development
- Use of Janus kinase inhibitors during early pregnancy in patients with rheumatic disease: a case series
- Synovial and serum S100A4 expression in rheumatoid arthritis is observed across disease stages and synovial pathotypes
- Challenges in implementing the 2020 EULAR Points to Consider on nonadherence in RMDs
- From lifelong immunosuppression to long-term drug-free remission: are finite therapies emerging in autoimmune diseases?
- Implementation of scientific evidence into rheumatological care—the viewpoint of the EULAR
- LLM-supported self-diagnosis and self-treatment of familial Mediterranean fever: a case report
- Adult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review
- Disseminated CNS tuberculosis in SLE without anti-TNF exposure: implications for LTBI screening in endemic settings—case report
- Combined interleukin-1 blockade for central nervous system inflammation in children with severe cryopyrin-associated periodic syndromes
- Survival and disease reactivation after autologous stem cell transplantation for systemic sclerosis: a single-centre cohort
- Corrigendum to ‘Comparison of the PK, PD, safety, tolerability, and immunogenicity of proposed biosimilar RGB-19 and tocilizumab in healthy Japanese males: a phase 1, randomised, crossover study’ [EULAR Rheumatology Open 1 (2025) 282–290]
- Corrigendum to ‘Synovial histopathology in rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs: an analysis of 1593 surgical specimens using the Rooney score’ [EULAR Rheumatology Open 2 (2026) 336–343]
- Immunometabolism and rheumatic disease—advancing targeted therapies
- Balancing immunosuppression and cancer survival in the treatment of immune checkpoint inhibitor–associated inflammatory arthritis